FDA Moves Forward With Exempting Phase I Drugs From GMPs

Drug Industry Daily
More than two years after withdrawing a final rule that would have exempted investigational drugs in Phase I testing from certain good manufacturing practice (GMP) regulations, the FDA is issuing a final rule to do just that.

To View This Article:


Subscribe To Drug Industry Daily